Evidence map›Paper›PMID 22302882›Full record

ArticleThe Journal of general virology2012

Bovine PrP expression levels in transgenic mice influence transmission characteristics of atypical bovine spongiform encephalopathy.

Rona Wilson, Patricia Hart, Pedro Piccardo, Nora Hunter, Cristina Casalone, Thierry Baron, Rona M Barron

Open access · greenAbstract read
In one paragraph

Article in The Journal of general virology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Insights into Mechanisms of Chronic Neurodegeneration.International journal of molecular sciences · 2016
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Rona WilsonNeurobiology Division, The Roslin Institute and R(D)SVS, University of Edinburgh, Roslin, Midlothian, UK.
Patricia HartNeurobiology Division, The Roslin Institute and R(D)SVS, University of Edinburgh, Roslin, Midlothian, UK.
Pedro PiccardoLaboratory of Bacterial and TSE-agents, Food and Drug Administration, Rockville, MD 20852, USA.
Nora HunterNeurobiology Division, The Roslin Institute and R(D)SVS, University of Edinburgh, Roslin, Midlothian, UK.
Cristina CasaloneIstituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, Turin, Italy.
Thierry BaronAgence Nationale de Sécurité Sanitaire, Lyon, France.
Rona M BarronNeurobiology Division, The Roslin Institute and R(D)SVS, University of Edinburgh, Roslin, Midlothian, UK.
Roslin Institute · GBIstituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle d'Aosta · ITUnited States Food and Drug Administration · USUniversity of Edinburgh · GB

Funding

Biotechnology and Biological Sciences Research Council BBS/E/D/05241340Biotechnology and Biological Sciences Research Council BBS/E/D/20251967Biotechnology and Biological Sciences Research Council BBS/E/D/20251968NIAID NIH HHS Y01 AI004893NIAID NIH HHS Y1-AI-4893-02PHS HHS 224-05-1307
6 · The paper itself

Abstract

Until recently, transmissible spongiform encephalopathy (TSE) disease in cattle was thought to be caused by a single agent strain, bovine spongiform encephalopathy (BSE) (classical BSE or BSE-C). However, due to the initiation of a large-scale surveillance programme throughout Europe, two atypical BSE strains, bovine amyloidotic spongiform encephalopathy (BASE, also named BSE-L) and BSE-H have since been discovered. These atypical BSE isolates have been previously transmitted to a range of transgenic mouse models overexpressing PrP from different species at different levels, on a variety of genetic backgrounds. To control for genetic background and expression level in the analysis of these isolates, we performed here a comprehensive comparison of the neuropathological and molecular properties of all three BSE agents (BASE, BSE-C and BSE-H) upon transmission into the same gene-targeted transgenic mouse line expressing the bovine prion protein (Bov6) and a wild-type control of the same genetic background. Significantly, upon challenge with these BSE agents, we found that BASE did not produce shorter survival times in these mice compared with BSE-C, contrary to previous studies using overexpressing bovine transgenic mice. Amyloid plaques were only present in mice challenged with atypical BSE and neuropathological features, including intensity of PrP deposition in the brain and severity of vacuolar degeneration were less pronounced in BASE compared with BSE-C-challenged mice.

Indexed as

Gene ExpressionAnimalsBrainCattleDisease Models, AnimalEncephalopathy, Bovine SpongiformMiceMice, TransgenicPrionsSeverity of Illness IndexSurvival AnalysisPrions

Identifiers

PMID22302882
PMCPMC3541801
OpenAlexW2119018165

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.